SURG: financial statements from SEC — TradeAlmanac

SURG

SurgePays, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024
Revenue	16m	19m	12m	11m	5m
Cost of revenue	24m	21m	14m	14m	13m
Selling, general and administrative	4m	4m	4m	5m	6m
Operating expenses	27m	26m	18m	18m	19m
Operating income	−11m	−7m	−7m	−8m	−14m
Pre-tax income	−12m	−7m	−7m	−8m	−14m
Net income	−12m	−7m	−7m	−8m	−14m
Earnings per share	−0.51	−0.38	−0.36	−0.38	−0.73
Earnings per share, diluted	−0.51	−0.38	−0.36	−0.38	−0.73
Weighted average shares	24m	20m	20m	20m	20m
Weighted average shares, diluted	24m	20m	20m	20m	20m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Oct 31, 2024	Sep 30, 2024
Cash and equivalents	2m	2m	3m	4m	5m	12m	—	14m
Short-term investments	—

Cash flow

Metric	Mar 31, 2026	Mar 31, 2025
Operating cash flow	−5m	−7m
Depreciation and amortisation	190,216	249,574
Investing cash flow	—	−18,590
Financing cash flow	5m	−410,545

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)